Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Genetic variants associated with schizophrenia and autism still have an impact on cognitive skills and brain structure in people who carry the genes but do not suffer from these conditions. This is one of the main findings from new research published in the journal Nature by scientists from the NEWMEDS project, which is supported by the Innovative Medicines Initiative (IMI). The findings add to our understanding of the risk factors that contribute to these conditions and could make it easier to study the neural and biochemical foundations of cognitive abilities.
It is now well known that people's genes can influence their risk of developing neuropsychiatric disorders like autism and schizophrenia. However, the picture is far from simple - most cases of these conditions are the result of complex interactions between a number of genes and the environment. This means that there are many people in the population who carry 'risk' genes but remain disease free.
In this study, researchers focused on 27 genetic variants that are known to be associated with an increased risk of schizophrenia and/or autism. The goal of the team was to determine whether healthy carriers of these variants displayed any of the cognitive difficulties or brain abnormalities found in people with schizophrenia, and then use this information to find out precisely which cognitive abnormalities put carriers at risk of developing schizophrenia. The researchers compared people with a schizophrenia diagnosis with healthy carriers of the risk variants, healthy carriers of other risk variants, as well as people who are free of the risk-associated variants. Healthy participants underwent brain scans as well as tests of cognitive skills that are known to be problematic in schizophrenia, such as attention, spatial working memory, logical memory, cognitive flexibility (the ability to think about multiple concepts or switch rapidly between different concepts), and language.
The results revealed that the cognitive abilities of healthy carriers of risk-associated genetic variants lie between those of schizophrenia patients and people without the risk variants. In addition, the brain scans showed that healthy carriers of the risk variants had brain abnormalities linked to schizophrenia and cognitive processes. The findings suggest that the cognitive abnormalities seen in people with schizophrenia are not necessarily a consequence of the disease; rather, having these cognitive problems may be a risk factor for the disease.
CNVs conferring risk of autism or schizophrenia affect cognition in controls, Hreinn Stefansson, Andreas Meyer-Lindenberg, Stacy Steinberg, Brynja Magnusdottir, Katrin Morgen, Sunna Arnarsdottir, Gyda Bjornsdottir, G. Bragi Walters, Gudrun Jonsdottir, Orla M. Doyle, Heike Tost, Oliver Grimm, Solveig Kristjansdottir, Heimir Snorrason, Solveig R. Davidsdottir, Larus J. Gudmundsson, Gudbjorn F. Jonsson, Berglind Stefansdottir, Isafold Helgadottir, Magnus Haraldsson, Birna Jonsdottir, Johan H. Thygesen, Adam J. Schwarz, Michael Didriksen, Tine B. Stensbøl, Michael Brammer, Shitij Kapur, Jonas G. Halldorsson, Stefan Hreidarsson, Evald Saemundsen, Engilbert Sigurdsson & Kari Stefansson, Nature (2013) doi:10.1038/nature12818
Innovative Medicines Initiative (IMI)
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Schizophrenia category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Initiative, Innovative Medicines. "Genetic variants linked with schizophrenia have impact in healthy carriers." Medical News Today. MediLexicon, Intl., 23 Dec. 2013. Web.
10 Mar. 2014. <http://www.medicalnewstoday.com/releases/270537>
Initiative, I. (2013, December 23). "Genetic variants linked with schizophrenia have impact in healthy carriers." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/270537.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.